Tande­mAI rais­es $35M in Se­ries A for small mol­e­cule dis­cov­ery, wet labs

Tande­mAI, a small mol­e­cule- and pre­clin­i­cal-fo­cused tech­nol­o­gy com­pa­ny, raised $35 mil­lion in a Se­ries A round of fi­nanc­ing a lit­tle over a year af­ter rais­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER